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Abstract 
 
Glioma initiating cells (GICs) are thought to contribute to therapeutic 
resistance and tumor recurrence in glioblastoma, a lethal primary brain 
tumor in adults. Although the stem-like properties of GICs, such as 
self-renewal and tumorigenicity, are epigenetically regulated, the role of a 
major chromatin remodeling complex in human, the SWI/SNF complex, 
remains unknown in these cells. Here, I demonstrate that the SWI/SNF core 
complex, which is associated with a unique corepressor complex through 
the d4-family proteins, DPF1 or DPF3a, plays essential roles in stemness 
maintenance in GICs. The serum-induced differentiation of GICs 
downregulated the endogenous expression of DPF1 and DPF3a, and the 
shRNA-mediated knockdown of each gene reduced both sphere-forming 
ability and tumor-forming activity in a mouse xenograft model. Rescue 
experiments revealed that DPF1 has dominant effects over DPF3a. Notably, 
whereas we have previously reported that d4-family members can function 
as adaptor proteins between the SWI/SNF complex and NF-κB dimers, this 
does not significantly contribute to maintaining the stemness properties of 
GICs. Instead, these proteins were found to link a corepressor complex 
containing the nuclear receptor, TLX, and LSD1/RCOR2 with the 
SWI/SNF core complex. Collectively, these results indicate that DPF1 and 
DPF3a are potential therapeutic targets for glioblastoma. 
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Introduction 
 
Glioblastoma multiforme (GBM) and glioma initiating cells (GICs) 
Glioblastoma multiforme (GBM) is the most common malignant brain 
tumor in adults and remains incurable with an average survival of slightly 
more than 1 year past the initial diagnosis in spite of modern surgical and 
medical therapies.  
Tumors are comprised of a highly heterogeneous population of cells and 
contain a subset of stem-like cells called cancer stem cells (CSCs), which 
have the ability to self-renew, differentiate into various cell types and 
regenerate tumors. Similar to other malignant tumors, large body of evidence 
now indicates that stem-like cells, designated as glioma initiating cells 
(GICs), are thought to drive GBM propagation and cause therapeutic 
resistance in these tumors [1-3, 6]. 
Stemness properties of GICs are characterized by their capacity for 
self-renewal as well as differentiation, expression of some neural 
stem/progenitor cell markers and their ability to induce tumorigenesis in 
immunocompromised mice with a very small number of cells [4-6]. To 
demonstrate the self-renewal and differentiation of single cancer stem cells, 
it will be important to show that single cells from a prospectively identified 
population of cancer stem cells can self-renew to generate phenotypically 
similar tumorigenic daughter cells, as well as differentiate into 
phenotypically diverse non-tumorigenic daughter cells during tumorigenesis 
in vivo [5]. However, it is possible that tumorigenesis by single cancer stem 
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cells is inherently inefficient because microenvironments that are permissive 
for tumorigenesis could be rare under many circumstances [1, 4-6]. 
GICs have been reported previously to retain their stemness properties 
when cultured as non-adherent spheres in a defined medium without serum 
supplemented with EGF and bFGF even more than 70 passages so far [7]. 
Orthotopic xenotransplantation of as few as 50 GICs leads to formation of 
tumors in the brains of SCID mice [8]. On the other hand, the differentiation 
of GICs can be induced by culturing the cells as an adherent monolayer in 
medium containing serum [7]. During the differentiation, GICs lose their 
stemness properties like potent tumorigenesity and stem cell marker genes 
expression, and orthotopic xenotransplantation of as many as 105 
differentiated cells fails to initiate tumors in the brains of any SCID mice  
[7, 8]. 
   Three independent cell isolates from GBM patients (TGS-01, -04 and 
-05) have been reported previously to have these GIC properties when 
cultured as non-adherent spheres in a defined medium without serum [9]. 
These cells have the ability to self-renew and mimic the original tumor after 
transplantation into the brains of immunocompromised mice [9]. The 
differentiation of these three GIC isolates can be induced by culturing the 
cells as an adherent monolayer in medium containing serum [7, 9]. 
 
Epigenetics of GICs 
Chromatin structure modification has been shown to be an important 
determinant of GIC stemness maintenance as well as the induction of their 
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differentiation [10, 11]. Recently, using gene expression data from both 
stem-like and differentiated cell populations, it was shown that the 
simultaneous expression of four core transcription factors, POU3F2, SALL2, 
SOX2, and OLIG2, can reprogram differentiated GBM cells into 
spherogenic stem-like tumor-propagating cells [8]. These results 
demonstrate a plastic developmental hierarchy in GBM cell populations and 
reveal essential roles of epigenetic regulation in these biological processes 
[12]. 
 
Function and components of SWI/SNF complex 
In humans, the ATP-dependent chromatin remodeling factor, SWI/SNF 
complex, has been reported to play essential epigenetic roles in many 
biological processes [13-15]. As the catalytic subunit, each SWI/SNF 
complex has a single molecule of either BRG1 or Brm, but not both (Fig. 
1). The molecular components of these SWI/SNF complexes are now 
known to be highly polymorphic, in which some subunits that are encoded 
by homologous gene family members are integrated into the specific 
position of the complex in a mutually exclusive manner [13, 14, 16]. 
Importantly, exchange of a subunit with another family member has often 
been observed during several developmental processes within either the 
SWI/SNF core complex or its strongly associated cofactor proteins. Some 
of those exchanges are anticipated to be crucial for these developmental 
transitions. For example, BRG1 is much more abundant than Brm in 
embryonic and neural stem cells and is thus thought to be the major 
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functional catalytic subunit in these cellular contexts [13, 14, 17-19]. In a 
similar mutually exclusive manner, one of DPF1, DPF2 (REQ/BAF45D), 
DPF3a or DPF3b (a splicing variant of DPF3a), which comprise the 
d4-family proteins, is a cofactor that substoichiometrically interacts with 
human SWI/SNF complexes. 
 
d4-family proteins 
We have previously demonstrated that DPF2 functions as an efficient 
adaptor protein between the SWI/SNF complex and the RelB/p52 dimer 
[20]. By examining all of the d4-family proteins (DPF1, 2, 3a and 3b), we 
further found that high level exogenous expression of each of these factors 
can potentiate the transactivating activity of typical NF-κB dimers 
including RelA/p50, which is responsible for the canonical NF-κB pathway, 
and RelB/p52, which is the most downstream factor of the non-canonical 
NF-κB pathway [21]. In addition, we demonstrated from our analysis in 
293FT cells that DPF3a and 3b are the most effective cofactors of the 
SWI/SNF complex for RelA/p50 activation. These previous observations 
are schematically represented in Figure 2. 
 
The propose of this study 
  In the current study, I show that knockdown of either DPF1 or DPF3a 
promptly abolishes stemness maintenance of GICs. I have demonstrated 
that through these d4-family proteins, a distinct SWI/SNF core complex is 
associated with specific corepressor complexes and further that such larger 
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SWI/SNF complex is an essential determinant of the key features of GICs. 
Therefore, DPF1 and DPF3a would be possible new therapeutic targets for 
GBM.   
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Results 
 
DPF1 and DPF3a/b transcripts are abundant in GICs in sphere 
cultures but are downregulated upon differentiation. 
To identify the genes enriched in GIC sphere cultures, I isolated total 
RNA and protein from 3 respective pairs of sphere and differentiated 
monolayer GIC cultures (TGS-01, -04 and -05 [9]). By qRT-PCR and 
western blotting using these GIC preparations, I checked the expression of 
the POU3F2, SOX2, SALL2 and OLIG2, which have been reported to be 
required for the reconstitution and maintenance of stemness [8] (Fig. 3, 4, 
5). By comparing the RNA and protein levels between the sphere and 
differentiated monolayer GIC cultures, I found that all 4 transcription 
factors were at higher levels in sphere culture, indicating that these GIC 
cultures had very similar properties to stem-like tumor propagating cells 
(TPCs) reported previously [8]. 
   Using the same samples, I next examined the expression levels of core 
components of SWI/SNF complex and of several proteins reported to be 
strongly associated with SWI/SNF complex. The mRNA (Fig. 3, 5) and 
protein (Fig. 6) levels of BRG1, the catalytic subunit thought to be 
involved in the stemness maintenance in embryonic and neuronal stem 
cells, were higher in sphere cultures than in differentiated cultures of all 
three GICs. Interestingly, among the d4-family members, DPF1 and 
DPF3a/b were found to be more abundant in sphere cultures (Fig. 3), 
although the expression levels of DPF3a/b varied among the three GIC 
10 
 
sphere cultures (Fig. 5).  
 
DPF1 and DPF3a play important roles in maintaining GIC stemness 
To test the possible involvement of BRG1 and the d4-family proteins in 
stem cell maintenance in GICs, I performed respective knockdown 
experiments using at least two sets of short-hairpin (sh)RNAs with efficient 
suppressing activity. shRNAs used in this study were either previously 
reported [21] or newly prepared (Fig. 7) and they were selected by the 
following criteria: mRNA levels of each target were specifically reduced to 
40% in 293FT or MDA-MB-231 cells. Preliminary experiments indicated 
that the biological effects of a DPF1 and DPF3a knockdown seemed to be 
so rapid that I could not isolate stable transductants in non-adherent sphere 
culture by puromycin selection. I therefore employed shRNA expression 
lentivirus vectors coexpressing GFP. To evaluate the stemness of GICs, I 
performed sphere forming assays in which GFP positive cells were 
single-sorted into a well at 48 hours after transduction and sphere forming 
activity was evaluated. The sphere forming assay is a widely used to 
demonstrate the self-renewing ability and believed to be able to evaluate 
the potential of a cell to behave as a stem-like cell when removed from its 
in vivo niche [22]. The knockdown of BRG1, DPF1, DPF3a, and DPF3b 
drastically reduced the sphere forming activity of TGS-01, whereas a DPF2 
knockdown showed only marginal effects in this assay (Fig. 8). To test 
whether this important function of DPF1 and DPF3a could be extended to 
the other GICs, I subjected TGS-04 and TGS-05 cells to a DPF1 or DPF3a 
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knockdown and found that, similar to TGS-01, sphere forming activity was 
reduced in both instances (Fig. 9).  
To eliminate the possibility of off-target effects by the shRNA 
constructs, rescue experiments were performed. Since the loss of stemness 
can be detected very early after vector transduction, I designed and 
developed dual lentivirus expression vectors (Fig. 10) carrying expression 
units of both shRNAs (driven by the mU6 pol III promoter) and the 
corresponding cDNA (driven by the EF1α pol II promoter known to be 
relatively resistant to gene silencing in stem cells), where the cDNAs were 
designed to be resistant to the corresponding shRNA. In the case of BRG1, 
DPF1 and DPF3a, the simultaneous expression of corresponding cDNA 
partially rescued the sphere forming activity (Fig. 11). Interestingly, DPF3a 
knockdown was also rescued by DPF1 cDNA expression, whereas DPF1 
knockdown was not significantly rescued by the exogenous expression of 
DPF3a (Fig. 11). These results suggest that DPF1 has dominant effects over 
DPF3a in terms of stem cell maintenance. Because rescue experiments 
using DPF3b cDNA in DPF3b knockdown cells were not successful and 
also because the mRNA levels of DPF3b are close to the limit of detection 
by qRT-PCR in these GICs, I did not further analyze DPF3b. It was notable 
that the exogenous expression of FLAG-tagged d4-family proteins, BRG1 
and Brm in TGS-01 cells did not increased sphere forming activity (Fig. 
12), indicating that the endogenous levels of these proteins were at 
saturated levels sufficient to maintain stemness.  
The extent of rescues using dual expression vectors were only partial. 
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These results might reflect the prompt effects of shRNAs which appeared 
before the exogenous protein expression reached stable levels. To exclude 
this possibility, I prepared TGS-01 cells stably expressing the each 
d4-family proteins in advance and additionally transduced with shRNA 
expression vectors. The expression levels of exogenous DPF1 and DPF3a 
proteins were roughly the same, whereas the expression level of DPF2 was 
slightly lower (Fig. 13). As shown in Figure 14, when shDPF1 and 
shDPF3a were introduced into cells expressing the corresponding cDNA, 
the sphere forming activity was partially recovered again. Moreover, 
DPF1-introduced cells showed higher sphere forming activity compared 
with EV-2-introduced cells did when shDPF3a was expressed by another 
virus vector. On the other hand, cells exogenously expressing DPF3a were 
found to be sensitive to an additional DPF1 knockdown. These results 
confirmed the previous observations with dual expression vectors, i.e. that 
DPF1 is dominant over DPF3a. In these experiments however, the recovery 
of sphere forming activity through corresponding cDNA expression was 
generally incomplete. Whereas the EF1α promoter used to express 
d4-family proteins has been reported to be active in most cell types 
including primary and stem cells, and to be relatively resistant to gene 
silencing, it is now known that its activity is gradually lost during long-term 
culture in embryonic stem cells, neural precursors and neuronal cells [23, 
24]. These results showing insufficient rescues in GICs might be at least 
partly derived from the difficulty in long-term exogenous expression in 
GICs.  
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BRG1 can be functionally substituted by Brm as a catalytic subunit of 
the SWI/SNF core complex that contributes to GIC stemness. 
Whereas the higher expression levels of Brm mRNA in differentiated 
cultures were basically similar among the three GICs cultures, Brm mRNA 
levels in sphere cultures of TGS-04 and TGS-05 were considerably higher 
than in the TGS-01 cultures (Fig. 5). When Brm proteins in TGS-04 and 
TGS-05 cells were analyzed by western blotting (Fig. 6), unlike mRNA 
levels, the protein levels were higher in sphere cultures than in 
differentiated cultures, indicating that there would be some 
post-transcriptional regulation of Brm expression in these cells. These 
results also suggest heterogeneity in the SWI/SNF components among the 
three GIC cultures. 
   I further found that the sphere forming activity of both TGS-04 and 
TGS-05 was insensitive to both BRG1 and Brm knockdown (Fig. 15a, b). 
This finding contrasted with the observations in TGS-01 cells (Fig. 8), in 
which the BRG1 knockdown caused a reduction in sphere forming activity. 
I hypothesized that because of the high expression of both BRG1 and Brm 
proteins in TGS-04 and 05 cells (Fig. 6), a single knockdown of either may 
not have significantly affected sphere forming activity. This was probably 
because Brm can also function as an effective catalytic subunit of 
SWI/SNF complex for the stem cell maintenance of GICs.  
   To test whether Brm could indeed functionally substitute for BRG1, I 
next coexpressed Brm and shBRG1 in TGS-01 cells. The sphere forming 
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activity in these transfectants was rescued by Brm expression (Fig. 16), 
whereas the exogenous expression of Brm was not substantially affected 
the sphere forming activity (Fig. 12). These results indicate that Brm, if 
expressed in GICs at high protein levels, can also contribute to the 
maintenance of stemness. Therefore, at least in terms of maintaining GIC 
stemness, the frequently observed enrichment of BRG1 in sphere cultures 
does not mean that Brm cannot also perform the same biological activity. 
 
DPF1 and DPF3a knockdowns in GICs produce strong 
anti-tumorigenic activity. 
It is reported that, when GICs are injected into the brain of 
immunocompromised mice, these mice were gradually lose weights with 
neurological symptoms including lethargy, poor feeding, paralysis, 
appearance of distress such as poor mobility, self-mutilization, hunched 
posture, dehydration and skin ulcers, and eventually die due to the tumor 
progression with infiltration into the surrounding normal brain [25]. To 
further confirm the stemness maintenance function of DPF1 and DPF3a, I 
examined the tumorigenicity which is the representative stemness property. 
TGS-01 cells transduced with shDPF1 or shDPF3a expression vectors as 
well as an EV-2 (control) cells were orthotopically inoculated into 
immunocompromised mice (nude mice). Although I saw a rapid reduction 
in the survival rate of mice inoculated with the control cells, both shDPF1 
and shDPF3a expression improved this survival rate (Fig. 17). All mice, the 
body weights of which was measured during 1-4 days before death (7 
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mice) had lost their body weight compared with the previous time point of 
measurement (Fig. 18) In these mice, I often observed neurological 
symptoms such as poor mobility. Furthermore, when some dead mice were 
dissected, the invasion of the tumor in their brain was always observed. 
Notably, the expression of shDPF1 produced much greater effects 
compared with shDPF3a (5/6 mice showed full survival). These results 
confirmed that DPF1 has more profound effects on the maintenance of GIC 
stemness and thus further revealed that it has potential as a therapeutic 
target in GBM.    
 
Stemness maintenance by DPF1 and DPF3a does not require NF-κB 
activation 
In our previous studies using epithelial tumor cell lines, the d4-family 
members were shown to function as adaptor proteins linking the SWI/SNF 
complex with NF-κB dimers [20, 21]. Considering the strong dependency 
of GIC stemness maintenance on BRG1, DPF1 and DPF3a expression, I 
next tested whether SWI/SNF-dependent NF-κB activation contributed to 
this biological activity. IκBα is a NF-κB inhibitor, and IκBαSR is its mutant, 
which cannot be phosphorylated at the specific serine residues targeted by 
IKK and therefore reduces NF-κB activity efficiently [26]. When IκBαSR 
was introduced into TGS-01 cells, we did not detect any effects on sphere 
forming activity; the percentages of sphere forming cells in EV-2 
transduced cells and IκBαSR expressing cells were 20.57 ± 1.59 % and 
21.35 ± 0.60 % respectively. To examine the activation status of 
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endogenous NF-κB in GICs, we performed immunofluorescence assays and 
investigated the subcellular localization of NF-κB dimers. As a result, I 
found that both RelA and RelB were predominantly localized to the 
cytoplasm in TGS-01 cells (Fig. 19). Furthermore, the expression levels of 
IL6 and IL8, which are representative SWI/SNF-dependent NF-κB target 
genes, were very low in sphere cultures compared to those in differentiated 
cultures (Fig. 20). Collectively, these results suggest that DPF1 and DPF3a 
have distinct functions other than adaptors between NF-κB and the 
SWI/SNF complex in GICs to play essential roles in the maintenance of 
stemness.   
 
Formation of a large complex comprising the SWI/SNF core complex 
and a corepressor complex requires DPF1 and DPF3a adaptors. 
Given the observation of the prompt and strong suppression of stemness 
maintenance by shDPF1, and to a lesser extent by shDPF3a, I hypothesized 
that DPF1 as well as DPF3a can function as adaptors between SWI/SNF 
core complex and key transcriptional regulators which are essential for 
stemness of GICs. To examine this possibility, antibodies against several 
candidate proteins were tested whether they are able to 
coimmunoprecipitate with subunits of the SWI/SNF complex. Among the 
possible candidates that would form large complexes with SWI/SNF core 
complex, I found that antibodies against TLX (NR2E1), LSD1 
(lysine-specific demethylase 1) and RCOR2 (REST corepressor 2; 
CoREST2) coimmunoprecipitate both BRG1 and BAF155 from TGS-01 
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cell lysates (Fig. 21a, b). TLX, a nuclear orphan receptor with 
transcriptional suppressing function, has been previously shown to control 
the neuronal stem cells [27-29] and to be essential for maintaining the 
stemness of GICs by knockdown experiments [30]. LSD1, a negative 
epigenetic regulator with histone demethylase activity, has also been 
reported to regulate GIC stemness in combination with RCOR2 (REST 
corepressor2; CoREST2), a well-known corepressor [8]. Importantly, the 
protein levels of TLX was unchanged after induction of differentiation of 
these three GIC cultures whereas those of LSD1 and RCOR2 were enriched 
in sphere cultures (Fig. 6). When TGS-01 lysates were immunoprecipitated 
using a TLX antibody, I detected LSD1 and HDAC2 in these 
immunoprecipitates (Fig. 21a). Moreover, when these lysates were 
immunoprecipitated with an LSD1 antibody, I detected RCOR2, and vice 
versa (Fig. 21b), confirming previous reports of tight dimer formation 
between these two proteins [8, 31]. Similarly, when TGS-04 and TGS-05 
cellular lysates were immunoprecipitated with TLX antibody, both BRG1 
and BAF155 were detected in the immunoprecipitates (Fig. 22). 
Furthermore when lysates of TGS-01 cells exogenously expressing 
FLAG-tagged DPF1 or DPF3a were immunoprecipitated with either a TLX 
or LSD1 antibody, DPF1 or DPF3a as well as BRG1, BAF155 and LSD1 
were detected (Fig. 23a, b). FLAG-tagged DPF2 was also detected but at 
considerably lower levels. Overall, these results suggest that DPF1 and 
DPF3a can function as adaptor proteins linking the SWI/SNF complex and 
corepressor complexes containing TLX and LSD1/RCOR2. 
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Considering that the biochemical protocols used to lyse cells and isolate 
protein complexes from extracts are prone to disrupt bona fide protein 
interactions in cellular nuclei, I next used the in situ proximity ligation 
assay (PLA) as this method is suitable for visualizing interactions between 
proximally positioned proteins in cells after fixation of large labile 
complexes. A schematic diagram of this method is shown in Figure 24. In 
the preliminary studies using normal IgG, only marginal signals were 
detected. All of the proteins analyzed (BRG1, BAF155, TLX and LSD1) 
were confirmed to be strictly localized in the nucleus by 
immunofluorescence assay (Fig. 25) and the same antibodies were used for 
PLA. Similar to the positive control using the anti-BRG1/anti-BAF155 
antibody pair (two subunits of SWI/SNF core complex), the 
anti-BRG1/anti-TLX, anti-BRG1/anti-LSD1, anti-LSD1/anti-TLX, and 
anti-LSD1/anti-BAF155 antibody pairs detected close localization between 
these 5 pairs of proteins (Fig. 26). When each single antibody was used, 
there were only a few signals detected (Fig. 26). TGS-01 cells transduced 
with FLAG-tagged DPF1 expression vector were analyzed by PLA, I was 
able to detect close localization between DPF1 and TLX, DPF1 and LSD1, 
and DPF1 and BAF155 (Fig. 27), whereas when only anti-FLAG antibody 
was used, there was only a few signals. From these results, the corepressor 
complex including TLX and LSD1 were shown to be closely associated 
with the SWI/SNF core complex. To examine impacts of DPF1 
knockdown on this larger SWI/SNF complex, TGS-01 cells expressing 
shDPF1 were analyzed by PLA. The results indicated that signals detecting 
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the proximal localization of BRG1 and TLX or BRG1 and LSD1 were 
drastically decreased, whereas those for BRG1 and BAF155 or LSD1 and 
TLX were unaffected (Fig. 28). These observations are consistent with the 
idea that DPF1 connects the SWI/SNF core complex and corepressor 
complex containing TLX and LSD1/RCOR2.     
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Discussion 
 
   I have here described differences in the subunit composition of the 
SWI/SNF core complex and their associated cofactors between sphere and 
differentiated monolayer cultures of GICs. I have also shown that among 
the mRNAs enriched in GIC sphere cultures, DPF1 and DPF3a play key 
roles in the stemness maintenance of these cells. By shRNA-mediated 
knockdowns in GICs, both proteins were shown to be essential for growth 
and sphere formation in culture and tumor propagation in a mouse 
orthotopic transplantation model (Fig. 8, 9, 11, 14, 17). The effects of 
DPF1 or DPF3a knockdowns on cellular survival and sphere formation 
were very rapid, which in itself suggests that DPF1 and DPF3a could be 
direct therapeutic targets for the suppression of GICs. When TGS-01 cells 
were transduced with vectors expressing shDPF1 or shDPF3a and 
transplanted into nude mice, the shDPF1 expressing cells showed much 
stronger anti-tumor forming activity than those transduced with shDPF3a 
(Fig. 17). This result is consistent with the findings from the in vitro sphere 
forming assays indicating that a DPF1 knockdown cannot be significantly 
rescued by DPF3a cDNA expression, whereas the sphere forming activity 
of DPF3a-knockdown cells can be rescued by DPF1 cDNA expression 
(Fig. 11, 14). Overall, DPF1 shows potential as a future therapeutic target 
for GBM.  
Coimmunoprecipitation experiments revealed the presence of a large 
protein complex containing both SWI/SNF core complex and a corepressor 
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complex (Fig. 21, 22, 23). However, a detailed description of this complex 
was difficult probably because the large complex is fragile. An antibody to 
the putative component could partly disrupt this complex when it binds to 
its antigen. It is also possible that the formation and dissociation of this 
large complex are in equilibrium in a cell. To resolve this problem, I fixed 
the labile large complexes in cells, and monitored proximally positioned 
proteins using PLAs (Fig. 26, 27). By this method, I was able to detect a 
close association between the SWI/SNF core complex and corepressor 
complex in the nuclei of GICs. The corepressor complex was found to be 
composed of the nuclear receptor TLX and LSD1/RCOR2 using various 
different pairs of antibodies. Since TLX is the only transcription factor 
which can bind directly to DNA in this large complex, I believe that this 
large complex has a transcriptional suppression function mediated through 
TLX in a SWI/SNF-dependent manner. In this regard, it is worth noticing 
that the well-known target genes that are suppressed by TLX, P21 [32, 33] 
and BMP4 [34], were found to be upregulated upon the induction of GIC 
differentiation (Fig. 29). Considering that the suppression of these two 
genes have been reported to be essential for stemness maintenance of GICs 
[35, 36], they might be the direct targets of the large complex. The model 
of the large complex formation is schematically represented in Figure 30. 
From these observations, I believe that TLX plays a crucial function in this 
large protein complex to maintain GICs. 
It is noteworthy that we have previously observed large complex 
formation between the SWI/SNF core complex and a complex containing 
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NRSF/COREST/mSin3A in epithelial tumors [37]. A subset of the 
SWI/SNF core was present in this larger complex and was found to be 
responsible for the suppression of such neuronal genes as synaptophysin, 
SCGI and synapsin1 in non-neural cells. The representative SWI/SNF core 
complex is also present and contributes to the basal expression of the IL-6 
gene in the same cell.  
   Shortly after the knockdown of DPF1, the stem-cell like properties of 
the GICs were rapidly suppressed and the proximal locations between 
BRG1 and TLX or between BRG1 and LSD1 were disrupted, whereas 
those between BRG1 and BAF155 or between TLX and LSD1 were 
unaffected (Fig. 28). Although the exact molecular components of the 
entire complex remain to be resolved, in the large complex detected in 
these current analyses, DPF1 probably function as linkers between the 
SWI/SNF core and corepressor.  
It should be pointed out in this regard also that a previous search was 
conducted for candidates for direct regulatory targets (transcription factors 
and epigenetic regulators) of the four core transcription factors (POU3F2, 
SOX2, SALL2 and OLIG2) that would mediate stemness maintenance by 
analyzing core nodes in the transcriptional network controlled by these four 
core factors [8]. Intriguingly, DPF1 was among those candidates and is 
suggested to function downstream of OLIG2. Interestingly, some other 
components in larger SWI/SNF complexes were identified, LSD1 and 
RCOR2 were also included in the list of candidates. Therefore, I believe 
that I have here isolated a protein complex that assembles many key 
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regulators to directly epigenetically regulate stemness in GICs. The 
possible adaptor protein, DPF1, which links the core SWI/SNF and 
corepressor complexes, is likely to be a very promising therapeutic target 
for disrupting only the large complex in GICs. 
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Materials and Methods 
 
Cell culture 
Three independent glioma initiating cells (GICs) termed TGS-01, TGS-04 
and TGS-05 were established as described previously [9]. All human 
materials and protocols used in this study were approved by the ethics 
committee of the University of Tokyo Hospital (24-69-250809) and 
Medical Mycology Research Center (MMRC), Chiba University (#10). All 
methods were performed in accordance with each university’s guideline 
and regulation. Informed consent was obtained from all patients. GICs 
were passaged in DMEM/F12 serum-free medium (Thermo Fisher 
Scientific) supplemented with B27 (Thermo Fisher Scientific), 20 ng/ml of 
EGF, and 20 ng/ml of bFGF (both from PeproTech) using ultra-low 
attachment dishes or flasks. Dulbecco’s modified Eagle’s medium 
containing 10% fetal bovine serum (FBS) was used to induce the 
differentiation of GICs and to passage 293FT and PLAT-A human 
embryonic kidney cells in culture. 
 
Plasmid construction 
For lentivirus construction, the DNA fragment containing EF1α promoter 
region was amplified by PCR from pXL001 (26122 [38], Addgene) using 
the primer sets listed in Table 1 and digested with NheI. pLSP [39] was 
digested with ClaI, blunt ended using T4 DNA Polymerase and then 
digested with XbaI. The resulting 1.5 kb and 5.1 kb fragments were ligated 
to generate pLE. Pairs of oligonucleotides containing multi cloning sites 
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(MCS) were synthesized as listed in Supplemental Table S1 and inserted 
into the EcoRV/ClaI sites of pLE to generate pLE-MCS. IRES-EGFP and 
IRES-Puror fragments were obtained by PCR from pMXs-IG [40] and 
pMXs-IP [40], respectively, using primer sets listed in Table 1 and were 
digested with XbaI and ClaI. The resulting 1.3kb and 1.2 kb fragments 
were inserted into the XbaI/ClaI site of pLE-MCS to generate pLE-IG 
(EV-2) and pLE-IP (EV-3), respectively. 
   For shRNA expression vectors, pairs of oligonucleotides encoding 
gene-specific short hairpin RNA (shRNA) were synthesized as listed in 
Table 1 and inserted into the BbsI/EcoRI sites of pmU6 [41]. The pmU6 
derivatives shCre#4 [42], shBrm#4 [43]  shDPF1-CDS#1 [21] and 
shDPF3a-3’UTR#2 [21] were previously described. These pmU6-based 
plasmids were doubly digested with BamHI and EcoRI, and inserted into 
the same sites of pSSCG [39] (EV-1) or pLE-IG (EV-2).  
   For exogenous expression, pairs of oligonucleotides encoding a 
3×FLAG tag were synthesized as listed in Table 1, annealed, extended, 
digested with BglII and MfeI, and inserted into the BglII/MfeI site in MCS 
of pLE-IG and pLE-IP. DPF1, DPF2, DPF3a, DPF3b, BRG1 and Brm 
fragments were amplified by PCR using primer sets listed in Table 1 and 
cloned into the BamHI-EcoRI site of pCR2.1. DPF1, DPF2, DPF3a and 
DPF3b fragments were digested with EcoRI and SalII, and inserted into the 
MfeI/XhoI site in MCS of pLE-IG and pLE-IP. BRG1 fragment was 
digested with MfeI and XbaI, and inserted into the MfeI/XbaI site in MCS 
of pLE-IG and pLE-IP. Brm fragment was digested with EcoRI and XhoI, 
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and inserted into the EcoRI/XhoI site in MCS of pLE-IG and pLE-IP. 
Site-directed mutagenesis was performed using a KOD-Plus-Mutagenesis 
kit (TOYOBO) in accordance with the manufacturer’s instructions to 
generate BRG1 shRNA resistant mutant with primer sets listed in Table 1. 
IκBαSR expression vector was kindly gifted by Prof. Shoji Yamaoka [26]. 
All plasmids were confirmed by DNA sequencing. 
 
DNA transfection and retro/lentivirus preparation  
For the transfection of plasmids into cells, Lipofectamine 2000 (Thermo 
Fisher Scientific) was used in accordance with the manufacturer’s 
instructions. Vesicular stomatitis virus-G (VSV-G) pseudotyped retrovirus 
vectors were produced using the prepackaging cell line PLAT-A. VSV-G 
pseudotyped lentivirus vectors were produced with the prepackaging cell 
line 293FT, using the ViraPower Lentiviral Expression System (Thermo 
Fisher Scientific), in accordance with the manufacturer's instructions. Three 
hours after transfection, the medium was changed to virus production 
serum-free medium (VP-SFM; Thermo Fisher Scientific) containing 4 mM 
L-glutamine. The transfection supernatant was collected after 24 and 48 
hours after transfection, filtered through a 0.45-μm filter, and centrifuged at 
6000 × g at 4°C for 16 hours. The pellets were suspended in culture 
medium for GICs. For transduction, GICs were incubated with the virus 
vector stocks at 37°C for 4 hours. All experiments were performed at low 
MOI (< 0.3). 
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RNA preparation and quantitative RT-PCR  
Total RNA was extracted using a mirVana microRNA Isolation Kit 
(Thermo Fisher Scientific). All RNA samples were then treated with 
TURBO DNase enzyme (TURBO DNA-free Kit; Thermo Fisher Scientific). 
To detect mRNAs, cDNA was synthesized with a PrimeScript RT Master 
Mix (TaKaRa Bio) in accordance with the manufacturer’s instructions. 
Quantitative real-time RT-PCR (qRT-PCR) was performed using a SYBR 
Select Master Mix (Thermo Fisher Scientific). GAPDH mRNA was used as 
an internal control. The primer pairs used are listed in Table 2. qRT-PCRs 
were performed in triplicate using a StepOne Plus real-time PCR system 
(Thermo Fisher Scientific). 
 
Western blotting 
Total protein extracts were prepared by boiling the cells in 2×SDS sample 
buffer for 10 min at 95°C. The proteins were then resolved by 10% 
SDS-PAGE and transferred onto Immobilon-P PVDF membranes 
(Millipore). Western blotting was performed by incubating the membrane 
in Can Get Signal Solution I (TOYOBO) containing primary antibodies 
overnight at 4°C. After three washes with Tris-buffered saline (TBS) 
containing 0.1% Tween 20, the membranes were incubated in Can Get 
Signal Solution II (TOYOBO) containing secondary antibodies [donkey 
anti-rabbit-horseradish peroxidase (AP182P; Millipore), Peroxidase 
AffiniPure Donkey Anti-Mouse IgG (715-035-150; Jackson 
immunoresearch), Peroxidase AffiniPure Donkey Anti-Goat IgG 
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(705-035-147; Jackson immunoresearch) and Anti-DDDDK-tag 
mAb-HRP-DirecT (M185-7; MBL)] for 1 hour at room temperature (RT). 
Signals were detected on an AE-9300H-CP Ez-CaptureMG (ATTO) 
imaging analyzer using ECL Western Blotting Substrate (Promega) or 
Immunostar DL (WAKO). The primary antibodies used are listed in Table 
3.  
 
Single-cell sphere formation assay  
Two days after the transduction with shRNA expression retrovirus vectors 
(pSSCG) or shRNA/cDNA dual expression lentivirus vectors (pLE-IG), 
GICs were dissociated with TrypLE express (Thermo Fisher Scientific) and 
GFP (+)/7-AAD (-) cells were sorted by FACS ARIA I or ARIA II (Becton 
Dickinson) at a density of 1 cell per well into ultra-low attachment 96-well 
plates (Corning) in 100 μl of DMEM/F12 serum-free medium. After 2 
weeks, the percentage of wells containing spheres was calculated.  
 
Intracranial proliferation assay 
Two days after transduction with shRNA expression lentivirus vectors 
(pLE-IG), GICs were dissociated and GFP (+)/7-AAD (-) cells were sorted 
by FACS ARIA I, centrifuged and resuspended in DMEM/F12 serum-free 
medium. A total of 3 × 103 cells (2 μl) were injected stereotactically into 
the right cerebral hemisphere of 6-week-old female BALB/c nu/nu mice 
(CLEA Japan) at a depth of 3 mm. All animal experimental protocols were 
performed in accordance with the policies of the Animal Ethics Committee 
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of the University of Tokyo and performed in compliance with University’s 
Guidelines for the Care and Use of Laboratory Animals. 
 
Immunoprecipitation 
Cells were lysed with a buffer containing 50 mM Tris-HCl (pH 7.5), 140 
mM NaCl, 1 mM MgCl2, 0.5mM DTT, 0.1% Tween20, protease inhibitor 
cocktail (Nacalai Tesque) and phosphatase inhibitor cocktail (Nacalai 
Tesque). Immunoprecipitation were performed using Dynabeads Protein G 
(Thermo Fisher Scientific) in accordance with the manufacturer's 
instructions. The antibodies used are listed in Table 3. 
 
Immunofluorescence and proximity ligation assay 
For immunofluorescence, GICs were seeded onto an 8-Well Lab-Tek II 
chamber slide (Nunc) coated with poly-L-lysine and left 5 minutes. The 
cells were then fixed with PBS containing 4% paraformaldehyde (Nacalai 
Tesque) for 10 min at room temperature (RT), washed twice with PBS and 
permeabilized with 0.2% Triton X-100 PBS for 15 min at RT. After 
washing twice with PBS, blocking was performed using a 1:1 mixture of 
5% BSA, 0.02% NaN3 PBS and Blocking one (Nacalai Tesque) for 1 hour 
at 37°C. The samples were then incubated overnight at 4°C with primary 
antibodies (listed in Table 3) in blocking buffer. The samples were washed 
twice and subsequently incubated with Alexa Fluor 546 or 488 conjugated 
secondary antibodies (Thermo Fisher Scientific, 1:1000) in blocking buffer 
in the dark for 1 hour at RT. The samples were mounted in Vectashield 
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Mounting Medium with DAPI (Vector Laboratories). Fluorescence was 
detected using a fluorescence microscope (BZ-X710; Keyence). Images 
were processed using Adobe Photoshop CS3 software.  
   For the proximity ligation assay (PLA), GICs were seeded, treated and 
incubated with primary antibodies as described above. The PLA was 
performed using the Duolink In Situ Starter Set ORANGE (Sigma) in 
accordance with the manufacturer’s instructions. Anti-mouse MINUS and 
anti-rabbit PLUS PLA probes were used. Fluorescence was detected using 
a fluorescence microscope (BZ-X710; Keyence).  
 
Statistical analysis.   
Results are presented as means ±S.D. Statistical significance for qRT-PCR 
assays and single-cell sphere formation assay was determined using a 
two-tailed Student’s t-test. For the survival analysis shown in Figure 13, 
differences in survival rates were evaluated by the log-rank test. 
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Figure 1: Schematic representation of the SWI/SNF complex. The 
SWI/SNF complex consists of a catalytic ATPase subunit (either BRG1 or 
Brm), the other core subunits and its strongly associated cofactor proteins. 
Some of these proteins are able to replace with another family member. 
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Figure 2: Schematic representation of the adapter function of 
d4-family proteins linking SWI/SNF complex and NF-κB dimers in 
epithelial tumor cell lines. DPF2 and DPF3 directly interact with 
Brm/BRG1, BAF155, INI1, RelA, p50, RelB and p52. High level 
exogenous expression of DPF1 can also potentiate the transactivating 
activity of NF-κB dimers. 
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Figure 3: Expression of mRNAs encoding the subunits of SWI/SNF 
core complex, its strongly associated proteins and four core 
transcription factors in three GIC preparations and their 
corresponding differentiated cells. mRNA expression in sphere cultures 
of TGS-01, -04 or -05 were analyzed by qRT-PCR and compared with 
those in differentiated monolayer cultures derived from these cultures. The 
heat map represents the log2 fold changes in gene expression (sphere 
culture/differentiated monolayer culture). Red and blue indicate higher and 
lower expression, respectively, in sphere cultures compared with 
differentiated monolayer cultures.  
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Figure 4: Specific expression of four core transcription factors in 
sphere cultures of GICs and in differentiated monolayer cultures 
derived from them. Relative gene expression levels of the four core 
transcription factors analyzed by qRT-PCR from the experiment described 
in Figure 1. Error bars represent standard deviation of the mean from 
triplicate experiments. S, sphere culture; D, differentiated monolayer 
culture.  
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Figure 5: Expression of mRNAs encoding the subunits of SWI/SNF 
core complex and its strongly associated proteins in three GIC 
preparations and their corresponding differentiated cells. Relative gene 
expression levels of the d4-family members, BRG1 and Brm analyzed by 
qRT-PCR from the experiment described in Figure 1. Error bars represent 
standard deviation of the mean from triplicate experiments. S, sphere 
culture; D, differentiated monolayer culture.  
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Figure 6: Expression of four core transcription factors and other 
proteins in sphere cultures of GICs and in differentiated monolayer 
cultures derived from them. Western blotting analysis of the four core 
transcription factors and other proteins. Blots in a black line box are 
originated from the same gel. The same set of protein samples was used for 
each blot. S, sphere culture; D, differentiated monolayer culture.  
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Figure 7: Suppression of mRNA levels by shRNAs designed for 
d4-family members, BRG1 and Brm. MDA-MB-231 cells, which 
expresses all of the d4-family members, BRG1 and Brm at significant 
levels were transduced with pSSSP-based retrovirus vectors expressing 
these shRNAs and control shRNA (shCre#4) as well as an empty vector 
(pSSSP [43]). mRNA levels were measured by qRT-PCR. The expression 
levels of cells transduced with the control vector were taken as 1.0 and 
error bars represent standard deviation of the mean from triplicate 
experiments.  
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Figure 8: Knockdown effects of d4-family members, BRG1 or Brm on 
the sphere forming activity of GICs. Relative sphere formation ratio of 
TGS-01 cells transduced with retrovirus vectors expressing various 
shRNAs or empty vector (EV-1; lane1); shCre#4 (lane 2), shDPF1-CDS#1 
(lane 3), shDPF1-3’UTR#4 (lane 4), shDPF2-3’UTR#3, #4 and #6 (lanes 
5-7), shDPF3a-3’UTR#2 (lane 8), and shDPF3a-3’UTR#4 (lane 9), 
shDPF3b-CDS#6 and #7 (lanes 10, 11), shBRG1-CDS#2 and #4 (lanes 12, 
13) and shBrm#4, and #8 (lanes 14, 15). Error bars represent standard 
deviation of the mean from triplicate experiments. 
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Figure 9: Effects of DPF1 and DPF3a knockdowns on sphere forming 
activity in GICs. Percentage of sphere forming cells in TGS-04 (a) and 
TGS-05 (b) cultures transduced with lentivirus based on pLE-IG expressing 
shDPF1-3’UTR#4  or shDPF3a-3’UTR#4 or empty vector (EV-2). Error 
bars represent standard deviation of the mean from triplicate experiments. 
**p < 0.01 by Student’s t-test.  
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Figure 10: Proviral structures of the dual lentiviral vectors, pLE-IG 
and pLE-IP, simultaneously expressing shRNA and the corresponding 
mRNA. Proviral structures of the dual lentiviral vectors; pLE-IG (a, b, c) 
and pLE-IP (d). mRNA expression is driven by the EF1αpol II promoter, 
whereas that of shRNA is driven by mU6 pol III promoter. Each mRNA 
was designed to be resistant to the corresponding shRNA. pLE-IG and 
pLE-IP vectors that lack the cDNA insertion (a) or shRNA expression unit 
(b, d) were also used to express only mRNA or shRNA, respectively. 
Empty vectors (EV-2; pLE-IG, EV-3; pLE-IP) have neither the cDNA nor 
shRNA expression unit. ΔU3, the U3 sequence from which major enhancer 
sequences were deleted; R, lentiviral R sequence; U5, lentiviral U5 
sequence; Ψ, lentiviral packaging signal. 
a 
b 
c 
d 
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Figure 11: Knockdown and rescue experiments using dual expression 
vectors. Relative sphere formation ratio of TGS-01 cells transduced with 
the dual lentivirus vectors based on pLE-IG simultaneously expressing 
mRNA (3×FLAG-DPF1, -DPF3a and -BRG1) and shRNA (shCre#4, 
shDPF1-3’UTR#4, shDPF3a-3’UTR#4, shBRG1-CDS#2) for the rescue 
experiments. Similar results were obtained from at least two independent 
experiments. Error bars represent standard deviation of the mean from 
triplicate experiments. NS = not significant, *p < 0.05, **p < 0.01 by 
Student’s t-test.  
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Figure 12: Effects of exogenous d4-family proteins, BRG1 and Brm 
expression on the sphere forming activity of TGS-01 cells. Percentage of 
sphere forming TGS-01 cells transduced with lentivirus based on pLE-IG 
expressing d4-family proteins or BRG1, or with an empty vector (EV-2). 
Error bars represent the standard deviation of the mean from triplicate 
experiments. 
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Figure 13: Expression levels of exogenously introduced d4-family 
proteins. TGS-01 cells were transduced with lentivirus vectors based on 
pLE-IP expressing d4-family proteins as well as an empty vector (EV-3). 
These cell lysates were analyzed by western blotting using anti-FLAG 
antibody. β-actin was used as the loading control. 
 
 
 
 
 
51 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Effects of DPF1 and DPF3a knockdowns on the sphere 
forming activity of TGS-01 cells exogenously expressing d4-family 
proteins. TGS-01 cells transduced with lentivirus vectors based on pLE-IP 
expressing d4-family proteins as well as an empty vector (EV-3) were 
additionally transduced with lentivirus vectors based on pLE-IG expressing 
shDPF1-3’UTR#4, shDPF3a-3’UTR#4, or shBRG1-CDS#2 as well as an 
empty vector (EV-2). Error bars represent standard deviation of the mean 
from triplicate experiments. **p < 0.01 by Student’s t-test.  
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Figure 15: Effects of a BRG1 or Brm knockdown on the sphere forming 
activity of TGS-04 and TGS-05 cells. Percentage of sphere forming cells 
in TGS-04 (a) and TGS-05 (b) cultures transduced with lentivirus vectors 
based on pLE-IG expressing shBrm or shBRG1 or empty vector (EV-2; 
lane 1); shBrm#4, and #8 (lanes 2, 3) and shBRG1-CDS#2 and #4 (lanes 4, 
5). Error bars represent standard deviation of the mean from triplicate 
experiments. 
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Figure 16: BRG1 knockdown and rescue experiments using dual 
expression vectors. Percentage of sphere forming cells in TGS-01 cultures 
transduced with the dual lentivirus vectors based on pLE-IG expressing 
3×FLAG-Brm and shBRG1 simultaneously for the rescue experiments. 
Lanes 2 and 4 are shBRG1-CDS#2, and lanes 3 and 5 are shBRG1-CDS#4. 
Error bars represent standard deviation of the mean from triplicate 
experiments. **p < 0.01 by Student’s t-test.  
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Figure 17: Kaplan-Meier survival curves of mice orthotopically 
injected with TGS-01 cells. TGS-01 cells transduced (3×103 cells in each 
case) with lentivirus vectors based on pLE-IG expressing 
shDPF1-3’UTR#4 or shDPF3a-3’UTR#4 or empty vector (EV-2) were 
sorted by flow cytometry two days after the transduction and injected into 
the cerebral hemisphere of 6-week-old female nude mice. *p < 0.05, **p < 
0.01 by log-rank test. 
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Figure 18: Body weight loss of the mice measured during 1-4 days 
before death. Body weights of 7 mice used in Figure 17 were measured 
during 1-4 days before the death (day 0). They were compared with those 
measured at the previous time point. #1-5 are identification numbers of the 
mice. 
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Figure 19: Subcellular localization of RelA and RelB in sphere cultures 
of TGS-01. Immunofluorescent assays were performed to detect RelA and 
RelB in TGS-01 cells. Nuclei were counterstained with DAPI. Scale bar 
indicates 10 μm. 
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Figure 20: Expression patterns of representative SWI/SNF-dependent 
NF-κB target genes in sphere cultures of GICs and in differentiated 
monolayer cultures derived from them. The expression levels of IL6 (a), 
and IL8 (b) in both sphere and differentiated monolayer cultures of GICs 
were analyzed by qRT-PCR and compared. Error bars represent the 
standard deviation of the mean from triplicate experiments.  
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Figure 21: Detection of larger SWI/SNF complexes that include TLX 
and LSD1/RCOR2 in GICs. Coimmunoprecipitation of SWI/SNF 
complex subunits with corepressor complex. TGS-01 lysates were 
immunoprecipitated with anti-TLX (a) or anti-LSD1 and anti-RCOR2 (b) 
antibodies, and the resulting immunoprecipitates were analyzed by western 
blotting. The samples were derive from the same experiment and the 
gels/blots were processed in parallel.  
 
a b 
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Figure 22: Detection of SWI/SNF complex/TLX interactions in GICs. 
TGS-04 and TGS-05 lysates were immunoprecipitated with TLX 
antibodies and the resulting immunoprecipitates were analyzed by western 
blotting. 
 
 
 
 
 
 
 
 
 
60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Detection of interactions between d4-family proteins and 
larger SWI/SNF complexes that include TLX and LSD1/RCOR2. 
TGS-01 cells exogenously expressing 3×FLAG-DPF1, -DPF2 or -DPF3a 
lysates were immunoprecipitated with anti-TLX antibody (a) or anti-LSD1 
antibody (b), and the immunoprecipitates were analyzed by western 
blotting. Arrows, FLAG-tagged d4-family proteins; arrowheads, IgG heavy 
chains.  
a 
b 
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Figure 24: Schematic representation of in situ proximity ligation assay 
(PLA). Two primary antibodies raised in different species (rabbit; Rb and 
mouse; Ms in this study) recognize the each target protein (Protein A or 
Protein B). Species-specific secondary antibodies (PLA probes), each with 
a unique short DNA strand (DNA oligonucleotide tail) attached to it, bind 
to the primary antibodies. When the PLA probes are in close proximity 
(<40 nm), the DNA strands can interact through a subsequent addition of 
two other circle-forming DNA oligonucleotides. Several-hundredfold 
replication of the DNA circle can occur after the amplification reaction, and 
a fluorescent signal is generated by labelled complementary 
oligonucleotide probes. Each detected signal is visualized as an individual 
fluorescent dot when viewed with a fluorescence microscope [44, 45].  
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Figure 25: Subcellular localization of BRG1, BAF155, TLX and LSD1. 
Immunofluorescent assays were performed to detect BRG1, TLX, LSD1 
and BAF155 in TGS-01 cells. The antibodies used were as described for 
the PLA experiments in Figure 18. Nuclei were counterstained with DAPI. 
Scale bar indicates 10 μm. Rb; rabbit, Ms; mouse. 
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Figure 26: Proximal localization of the SWI/SNF core complex, TLX 
and LSD1/RCOR2 in TGS-01 cells as detected by PLA. TGS-01 cells 
were fixed and incubated with a single antibody or pairs of antibodies. Red 
dots indicate interactions and nuclei were counterstained with DAPI (blue). 
The red fluorescence images were obtained using quick-full-focus function 
of the BZ-X710 (Keyence) at depth of about 10 μm. Scale bar indicates 10 
μm. Rb; rabbit, Ms; mouse. 
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Figure 27: Proximal localization of DPF1 and TLX, LSD1 or BAF155 
in TGS-01 cells exogenously expressing 3×FLAG-DPF1 as detected by 
PLA. TGS-01 cells exogenously expressing 3×FLAG-DPF1 were fixed 
and incubated with a single or pair of antibodies. Red dots indicate 
interactions and nuclei were counterstained with DAPI (blue). The red 
fluorescence images were obtained using quick-full-focus function of the 
BZ-X710 (Keyence) at depth of about 10 μm. Scale bar indicates 10 μm. 
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Figure 28: Effects of a DPF1 knockdown on the proximal localization 
of SWI/SNF core complex, TLX and LSD1/RCOR2 in TGS-01 cells as 
detected by PLA. TGS-01 cells transduced with lentivirus vectors based 
on pLE-IG expressing shDPF1-3’UTR#4 or an empty vector (EV-2) were 
fixed three days after the transduction and incubated with pairs of antibody. 
The number of dots per nucleus of GFP positive cells was counted. Error 
bars represent 95% confidence intervals of the mean (N = 50). 
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Figure 29: Expression patterns of TLX target genes in sphere cultures 
of GICs and in differentiated monolayer cultures derived from them. 
The expression levels of BMP4 (a), and p21 (b) in both sphere and 
differentiated monolayer cultures of TGS-01 were analyzed by qRT-PCR 
and compared. Error bars represent the standard deviation of the mean from 
triplicate experiments.  
 
 
 
 
 
 
 
a b 
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Figure 30: Schematic representation of the model of formation of a 
larger SWI/SNF complex that is required for stemness maintenance of 
GICs. The SWI/SNF core complex and a corepressor complex containing 
TLX, RCOR2, LSD1 and HDAC2 are linked through d4-family proteins 
and form a large complex.  
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Table 1. List of primer pairs used for plasmid constructions. 
shDPF1-3'UTR#4-sense 5’-TTTGAATTAACTTGTTCTGTGTATGCTTCCTGTCACA
TACACAGAACAAGTTAATTCTTTTTTG-3’ 
shDPF1-3'UTR#4-antisense 5’-AATTCAAAAAAGAATTAACTTGTTCTGTGTATGTGA
CAGGAAGCATACACAGAACAAGTTAATT-3 
shDPF2-3'UTR#3-sense 5’-TTTGTAGCTTCACCTTGTTATTCCGCTTCCTGTCACG
GAATAACAAGGTGAAGCTACTTTTTTG-3’ 
shDPF2-3'UTR#3-antisense 5’-AATTCAAAAAAGTAGCTTCACCTTGTTATTCCGTGA
CAGGAAGCGGAATAACAAGGTGAAGCTA-3’ 
shDPF2-3'UTR#4-sense 5’-TTTGCTCTTAACTGAATTGGGAGCGCTTCCTGTCAC
GCTCCCAATTCAGTTAAGAGCTTTTTTG-3’ 
shDPF2-3'UTR#4-antisense 5’-AATTCAAAAAAGCTCTTAACTGAATTGGGAGCGTGA
CAGGAAGCGCTCCCAATTCAGTTAAGAG-3’ 
shDPF2-3'UTR#6-sense 5’-TTTGGTGATCACAGGGTTCAAACAGCTTCCTGTCAC
TGTTTGAACCCTGTGATCACCTTTTTTG-3’ 
shDPF2-3'UTR#6-antisense 5’-AATTCAAAAAAGGTGATCACAGGGTTCAAACAGTG
ACAGGAAGCTGTTTGAACCCTGTGATCAC-3’ 
shDPF3a-3'UTR#4-sense 5’-TTTGAAATCGAAGCAATATCCTGTGCTTCCTGTCAC
ACAGGATATTGCTTCGATTTCTTTTTTG-3’ 
shDPF3a-3'UTR#4-antisense 5’-AATTCAAAAAAGAAATCGAAGCAATATCCTGTGTG
ACAGGAAGCACAGGATATTGCTTCGATTT-3’ 
shDPF3b-3'CDS#6-sense 5’-TTTGGGAACTGCTCAAAGAGAAAGGCTTCCTGTCAC
CTTTCTCTTTGAGCAGTTCCCTTTTTTG-3’ 
shDPF3b-3'CDS#6-antisense 5’-AATTCAAAAAAGGGAACTGCTCAAAGAGAAAGGTG
ACAGGAAGCCTTTCTCTTTGAGCAGTTCC-3’ 
shDPF3b-3'CDS#7-sense 5’-TTTGATGACCAGCTACTCTTCTGCGCTTCCTGTCACG
CAGAAGAGTAGCTGGTCATCTTTTTTG-3’ 
shDPF3b-3'CDS#7-antisense 5’-AATTCAAAAAAGATGACCAGCTACTCTTCTGCGTGA
CAGGAAGCGCAGAAGAGTAGCTGGTCAT-3’ 
shBrm#8-sense 5’-TTTGTGATAAACTACAAAGATAGGGCTTCCTGTCAC
CCTATCTTTGTAGTTTATCACTTTTTTG-3’ 
shBrm#8-antisense 5’-AATTCAAAAAAGTGATAAACTACAAAGATAGGGTG
ACAGGAAGCCCTATCTTTGTAGTTTATCA-3’ 
shBRG1-CDS#2-sense 5’-TTTGTTGGAAGTACATGATTGTGGGCTTCCTGTCAC
CCACAATCATGTACTTCCAACTTTTTTG-3’ 
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shBRG1-CDS#2-antisense 5’-AATTCAAAAAAGTTGGAAGTACATGATTGTGGGTG
ACAGGAAGCCCACAATCATGTACTTCCAA-3’ 
shBRG1-CDS#4-sense 5’-TTTGCGTATCGCGGCTTTAAATACGCTTCCTGTCACG
TATTTAAAGCCGCGATACGCTTTTTTG-3’ 
shBRG1-CDS#4-antisense 5’-AATTCAAAAAAGCGTATCGCGGCTTTAAATACGTGA
CAGGAAGCGTATTTAAAGCCGCGATACG-3’ 
EF1α-Fwd 5’-GTTTAAACGCCACAAATGGCAGTATTCATCCA-3’ 
EF1α-Rev 5’-AAAGCTAGCATCGATGATATCCTCACGACACCTGAA
ATGGAAGA-3’ 
MCS-sense 5’-ATCAGATCTCAATTGCTCGAGGCGGCCGCCAGCTGT
CTAGACAT-3’ 
MCS-antisense 5’-CGATGTCTAGACAGCTGGCGGCCGCCTCGAGCAATT
GAGATCTGAT-3’ 
IRES-EGFP-Fwd 5’-AAATCTAGAGGCCGCTACGTAAATTCCG-3’ 
IRES-EGFP-Rev 5’-AAAATCGATGCTCGACTTACTTGTACAGCTCGTCCA
TG -3’ 
IRES-Puror-Fwd 5’-AAATCTAGACGGCCGCTACGTAAATTCCG-3’ 
IRES-Puror-Rev 5’-AAAATCGATGCTCGATCAGGCACCGGGCTTGCGGGT
-3’ 
3×FLAG-sense 5’-AAAAAGATCTACTACCATGGACTACAAAGACCATG
ACGGTGATTATAAAGATCATGACAT-3’ 
3×FLAG-antisense 5’-TTTTCAATTGCTTGTCATCGTCATCCTTGTAGTCGAT
GTCATGATCTTTATAATCACCGT-3’ 
DPF1-Fwd 5’-GAATTCATGGGCGGCCTCAGCGCCCGCCCGA-3’ 
DPF1-Rev 5’-GTCGACGGTATCGATAAGCTTCTAGGTGAGGGTGAT
GTAAGC-3’ 
DPF2-Fwd 5’-GAATTCATGGCGGCTGTGGTGGAGAAT-3’ 
DPF2-Rev 5’-GTCGACGGTATCGATAAGCTTTCAAGAGGAGTTCTG
GTTCTGG-3’ 
DPF3a/b-Fwd 5’-GAATTCATGGCGACTGTCATTCACAAC-3’ 
DPF3a-Rev 5’-GTCGACGGTATCGATAAGCTTTTAGCAACTGCCCTT
TTTATCTG-3’ 
DPF3b-Rev 5’-GTCGACGGTATCGATAAGCTTCTAGGCCTGGCAGCC
AAA-3’ 
BRG1-Fwd 5’-CAATTGATGTCCACTCCAGACCCA-3’ 
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BRG1-Rev 5’-TCTAGAGTCAGTCTTCTTCGCTGCCA-3’ 
Brm-Fwd 5’-GAATTCATGTCCACGCCCACAGACCC-3’ 
Brm-Rev 5’-CTCGAGTCACTCATCATCCGTCCCAC-3’ 
BRG1(mutation)-Fwd 5’-ATATGATCGTCGACGAAGGTCACCGCATGAAGAAC-
3’ 
BRG1(mutation)-Rev 5’-ATTTCCATCTTATCTTGGCGAGGATGTGCTTGTCT-3’ 
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Table 2. List of primer pairs used for qRT-PCR. 
Gene Forward primer Reverse primer 
GAPDH CTCTGCTCCTCCTGTTCGAC TTAAAAGCAGCCCTGGTGAC 
Brm CAGAAGCAGAGCCGCATCA GGCCTGAAGTCTGTATTCCCG 
BRG1 AGATGTCTTCCGGGCCA AGCTGGTTCTGGTTAAATGGG 
INI1 GACGCCTTCACCTGGAACA CGTCAGCGGGTTCAAATCCA 
BAF155 TGACAGAGCAGACCAATCACA AGAACTCAGGAAGAGCACGC 
BAF170 ACGGCAAGAACAAGTCCAAGA GGCAGGCGGTAGAGGTAAGA 
BAF60A TGGTAGAATGGCACAGGACCG GGTAATCCAGCATCAGTAGGACA 
BAF60B AGGCGTACATGGATCTCTTGG GCTGGGACTGAACGTATTGGA 
BAF60C TCATCAGCGTGGACCCTTCA TTGGCCGTGGATAGGAGGAA 
BAF57 GGTCACGGCATCCTCTGGTA TCTCCCACAACTTTAGGTCAGG 
ARID1A CAGATGGGACACCCAAGACA GTCCAGAGGTTTCCTACCCAC 
ARID1B CGACTCTACGTCTGCGTCAA CGTTTAGGTTGGTTGCCAGC 
BAF53A ACAGTGGAACGGAGGTTTAGC GGGAACTCTTTCTCAAGGGCA 
BAF53B CGTCAAGTCTGAGCCAAACC GCAGGAATGTTGTACTGCTCG 
DPF1 CCGGAAGGGAGCTGGA CAGGTAGGCGAGCACCAC 
DPF2 CAGAGGAACAGGGAAGATGGC ACTCCGGTCTGTGAGTCCAA 
DPF3a TCAGACAACACAGGAGCCAG AACTGAGGCCATTCCCAAGG 
DPF3b AGCTACTCTTCTGCGATGACTG TTCTCTTTGAGCAGTTCCCAGC 
SS18 GATGAACGGCCAGATGCCTG TGATGATGGCACAGAATGGTTG 
CREST AACATGCAGTCCAACCCAGTCTC CCTGCGCCGAGCTGTAGTG 
BRD9 CTGCTCTACTCAGCCTACGG GCATCCTTCACAAACTCCTGC 
BCL7A AGGCAAGGACGAGAAGTGTG GCTGGAGTTGCTGCTGTTC 
BCL7B AAGTGGGTGACTGTGGGTGA AGGCATCAGAAGGAAAGCCA 
BCL7C GGCCAAGAGAGAGATCCCG CCTCAGCTTCCAGCAGTTC 
BCL11A CGCCGCAAGCAAGGCAAA CGTGGTCTGGTTCATCATCTGTAA 
BCL11B ATGGGGAGAGAAGGAGACTGAA CGGCTGACGGTTACTTAGGAC 
POU3F2 GCCCTCTTGTTCCCTCTCTAA ACACATCATTACACCTGCTACC 
SOX2 GAGGGGTGCAAAAGAGGAGA CGTGAGTGTGGATGGGATTG 
SALL2 TCTTCCACCTTTACCACCCAC AGATGAGGCGAGGCAATCAG 
OLIG2 ACACAAATGGTAAACTCCTCCA ACACGGCAGACGCTACAAA 
BMP4 GGATCTTTACCGGCTTCAGTC GGGATGTTCTCCAGATGTTCTTC 
p21 GCAGACCAGCATGACAGATTTC ATGTAGAGCGGGCCTTTGAG 
IL6 AGTAACATGTGTGAAAGCAGCAA AAACTCCAAAAGACCAGTGATGA 
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IL8 GGTGCAGTTTTGCCAAGGAG TTCCTTGGGGTCCAGACAGA 
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Table 3. List of primary antibodies used in this study. 
Application Name Host Supplier  Catalog No. Dilution 
Western blotting anti-SOX2 Rabbit Abcam ab92494 1/500 
anti-SALL2 Rabbit Bethyl A303-208A 1/2500 
anti-POU3F2 Goat Santa Cruz sc-6029 1/200 
anti-OLIG2 Rabbit Millipore AB9610 1/500 
anti-β-actin Mouse Santa Cruz sc-47778 1/5000 
anti-BRG1 Rabbit Santa Cruz sc-10768 1/200 
anti-Brm Rabbit Abcam ab15597 1/1000 
anti-BAF155 Goat Santa Cruz sc-9747 1/500 
anti-LSD1 Rabbit Abcam ab129195 1/1000 
anti-RCOR2 Rabbit Santa Cruz sc-102078 1/200 
anti-TLX Mouse Perseus Proteomics PP-H6506-00 1/1000 
anti-HDAC2 Rabbit Santa Cruz sc-7899 1/200 
Immunoprecipitation normal rabbit IgG Rabbit Santa Cruz sc-2027 2μg/sample 
normal mouse IgG Mouse Santa Cruz sc-2025 2μg/sample 
anti-TLX Mouse Perseus Proteomics PP-H6506-00 2μg/sample 
anti-LSD1 Rabbit Abcam ab17721 2μg/sample 
anti-RCOR2  Rabbit Abcam ab37113 2μg/sample 
Immunofluorescence 
and 
proximity ligation assay 
anti-BRG1 Mouse Santa Cruz sc-17796 1/50 
anti-BAF155 Rabbit Abcam ab72503 1/200 
anti-TLX Rabbit Santa Cruz sc-292096 1/50 
anti-LSD1 Rabbit Abcam ab17721 1/200 
anti-LSD1 Mouse Cell Signaling #4218 1/100 
anti-FLAG Mouse Sigma-Aldrich F1804 1/1000 
anti-RelA Rabbit Santa Cruz sc-372 1/50 
anti-RelB Rabbit abcam ab33907 1/100 
 
 
 
 
 
